Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-19
    E.g., 2018-08-19

Archive Search

10 results
11:09 AM, Jun 01, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

JHL raises $106M in bond deal

Biosimilars company JHL Biotech Inc. (Zhubei, Taiwan) raised $106 million on May 15 in convertible bonds led by new investor VMS Investment Group, according to JHL CFO Ellis Chu. Also participating were new investor Ruihua...
11:36 AM, Jan 19, 2018  |  BC Week In Review | Clinical News  |  Regulatory

EC approves Amgen's biosimilar Avastin

market Avastin. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif.  Allergan plc (NYSE:AGN), Dublin, Ireland  Product: Mvasi biosimilar bevacizumab
7:33 PM, Nov 16, 2017  |  BC Week In Review | Clinical News  |  Regulatory

CHMP recommends Amgen's Avastin biosimilar ABP 215

marketing reasons." Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif.  Allergan plc (NYSE:AGN), Dublin, Ireland  Product: Mvasi biosimilar bevacizumab
2:09 PM, Sep 15, 2017  |  BC Week In Review | Clinical News  |  Regulatory

FDA approves first biosimilar for cancer

against VEGF. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif.  Allergan plc (NYSE:AGN), Dublin, Ireland  Product: Mvasi biosimilar bevacizumab
12:31 PM, Jul 14, 2017  |  BC Week In Review | Clinical News  |  Regulatory

FDA panel backs approval of Amgen's Avastin biosimilar

Allergan plc (NYSE:AGN). Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif.  Allergan plc (NYSE:AGN), Dublin, Ireland  Product: Biosimilar bevacizumab
1:19 PM, Jun 09, 2017  |  BC Week In Review | Clinical News  |  Regulatory

FDA panel to discuss Avastin biosimilar from Amgen, Allergan

7, 2016 ). Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif.  Allergan plc (NYSE:AGN), Dublin, Ireland  Product: Biosimilar bevacizumab
9:20 AM, Dec 16, 2016  |  BC Week In Review | Company News  |  Deals

JHL, Sanofi deal

NT$90 in a separate private placement. The deal also includes options for rights to JHL’s biosimilar bevacizumab
2:31 PM, Dec 07, 2016  |  BC Week In Review | Clinical News  |  Regulatory

ABP 215 regulatory update

2, 2012 ). Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif.  Allergan plc (NYSE:AGN), Dublin, Ireland  Product: Biosimilar bevacizumab
12:00 AM, Feb 03, 2014  |  BC Week In Review | Clinical News  |  Clinical Status

Biosimilar bevacizumab: Phase III started

its pharmaceuticals business into AbbVie last year. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif.   Product: Biosimilar bevacizumab
12:00 AM, Oct 29, 2012  |  BC Week In Review | Clinical News  |  Clinical Status

biosimilar bevacizumab: Development planned

Kirin Co. Ltd. (Tokyo:4151), Tokyo, Japan   Fujifilm Holdings Corp. (Tokyo:4901), Tokyo, Japan   Product: biosimilar bevacizumab